https://doi.org/10.1016/s0140-6736(18)32752-1
M
Max Robinson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
274
Papers
7.9K
Citations
41
h-index
108
i10-index
Max Robinson is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Head and Neck Cancer Studies & Head and Neck Surgical Oncology & Oral Health Pathology and Treatment. The author has an h-index of 41, co-authored 233 publications.
ORCID: 0000-0003-4491-6865Papers by this author
worksRadiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
2018 · The Lancet · 1,004 citations
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
2003 · Gene Therapy · 783 citations
https://doi.org/10.1038/sj.gt.3301885
HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology
2016 · Cancer Research · 210 citations
https://doi.org/10.1158/0008-5472.can-16-0633
Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach
2019 · British Journal of Cancer · 111 citations
https://doi.org/10.1038/s41416-019-0414-9
HOPX functions as a tumour suppressor in head and neck cancer
2016 · Scientific Reports · 41 citations
https://doi.org/10.1038/srep38758
Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility
2011 · British Journal of Cancer · 33 citations
https://doi.org/10.1038/bjc.2011.96
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat